2 Patents
- US124600052025Binding Molecules Specific for Claudin 18.2, Compositions and Methods Thereof, for Treatment of Cancer and Other Diseases
Sparx Bioscience Limited
0 cites - US119705332024Bispecific Antibodies Targeting Human Claudin 18.2 and Programmed Death-ligand 1 (PD-L1)
SPARX BIOSCIENCE LIMITED
0 cites